MAPT and Schnyder corneal dystrophy: Additionally, we first estimated that the CSF biomarker P-tau could partially mediate the effects of SCD on POD with a proportion of mediation (proportion = 31.25%, IE = 4.279 × 10−2, p < 0.001).